Healthcare / Health Information ServicesTSXV
$0.01
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $-2.7M · quality 64.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
17/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3M
P/E
N/A
•EV/EBITDA
N/A
•ROE
85.1%
↑Gross Margin
N/A
•Debt/Equity
-1.27
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-2.6%
FCF CAGR
—
FCF margin
-26.5%
FCF / Net income
0.18x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $10.0M · net income $-14.9M · FCF $-2.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $10.0M | $10.0M | $10.6M | $10.0M | $10.9M |
| Net Income | $-14.9M | $-14.9M | $-5.9M | $-4.7M | $-250000.00 |
| EBITDA | $-9.9M | $-9.9M | $-3.1M | $-3.3M | $459000.00 |
| EPS | — | — | -0.07 | -0.09 | -0.01 |
| Operating Margin | -34.0% | -34.0% | -30.7% | -35.2% | -7.3% |
| Net Margin | -148.6% | -148.6% | -55.6% | -46.8% | -2.3% |
| Balance Sheet | |||||
| Debt/Equity | -1.27 | -1.27 | -3.36 | -20.10 | 5.55 |
| Current Ratio | 0.03 | 0.03 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-2.7M | $-2.7M | $-4.1M | $-1.1M | $-768000.00 |
| Returns | |||||
| ROE | 85.1% | 85.1% | 146.9% | 1566.6% | -27.1% |
| Valuation | |||||
| EV/EBITDA | — | — | — | — | 23.37 |
| P/B | — | — | — | — | 6.81 |
| Growth & Yield | |||||
| Revenue Growth | -4.9% | -4.9% | 5.5% | -7.7% | — |
| EPS Growth | — | — | 22.2% | -1400.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-62.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.07 → n/d
Residual
-62.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.